Navigation Links
Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81.
Date:10/25/2011

income$
349$
290Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization7969Deferred income taxes45Stock-based compensation expense1315Restructuring costs, net of payments56Impairment cost-7Other-(4)Changes in operating assets and liabilities:Accounts receivable(46)(29)Inventories(45)1Accounts payable64Income taxes(2)(3)Other, net1036Net cash provided by operating activities373397Cash flows from investing activities:Capital expenditures(73)(65)Purchases of short-term investments(29)(27)Proceeds from sales of short-term investments2025Proceeds from sale of property, plant and equipment2-Acquisitions of businesses, net of cash acquired(75)(5)Other, net(3)(2)Net cash used in investing activities(158)(74)Cash flows from financing activities:Net issuance / (repayment) of short-term debt291Repayment of long-term debt-(100)Payment of dividends(65)(58)Share repurchases(134)(76)Exercise of stock options2724Excess tax benefits from stock-based payments55Net cash used in financing activities(138)(204)Effect of exchange rate changes on cash(3)8Net change in cash and cash equivalents74127Cash and cash equivalents at January 1569373Cash and cash equivalents at September 30$
43$
500Free cash flow(1)$
300$
332(1) Net cash provided by operating activities less capital expenditures.SIGMA-ALDRICH CORPORATIONSupplemental Financial Information - (Unaudited)Sales Growth by Business UnitThree MonthsEnded September 30, 2011CurrencyAcquisitionAdjustedReportedBenefitBenefit(Organic)   Research Essentials15%6%3%6%   Research Specialties12%6%4%2%   Research Biotech12%6%-6%   Research Chemicals13%6%3%4%   SAFC8%4%2%2%   Total Customer Sales11%5%2%4%Nine MonthsEnded September 30, 2011CurrencyAcquisitionAdjustedReportedBenefitBenefit(Organic)   Research Essentials13%5%2%6%   Research Specialties11%5%3%3%   Research Biotech10%5%-5%   Research Chemicals12%5%3%4%   SAFC1
'/>"/>
SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
3. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
6. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
7. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
8. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
9. Sigma-Aldrich to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010
10. Sigma-Aldrich(R) Licenses RAFT Polymerization Technology From CSIRO(R)
11. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... LONDON , July 29, 2014 ... 2014 Global Frost & Sullivan Best Practices Award ... solution is a cloud-based platform that connects digital ... - such as providers, pharmaceutical companies, prevention and ... electronics. Each year, Frost & ...
(Date:7/29/2014)... , July 29, 2014   Health 2.0 ... a keynote alongside visionary physicians Eric Topol , ... at the Health 2.0 8th Annual Fall Conference ... This year, Health 2.0 is set to host ... of the larger session on Consumer Tech & Wearables: ...
(Date:7/28/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today ... webcast to discuss financial results for the second quarter of ... 2014 at 4:30 p.m. ET. Conference call ... 2014 Time: 4:30 PM ET Listen via Internet: http://ir.pharmacyclics.com/events.cfm ... A webcast replay will be available on the Pharmacyclics website ...
Breaking Medicine Technology:Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 2Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 4Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2
... Inc. (OTC Bulletin Board: WGBS ), a leading developer ... an overview of the company at the 13th annual BIO CEO ... Hotel, Tuesday, February 15, 2011 at 11:30 a.m. Eastern time.  The ... may be accessed at www.wafergen.com . The BIO ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ) ... protocols on its Sciclone® NGS Workstation for Illumina,s TruSeq™ ... In addition to the automation protocols for TruSeq kits, ... library preparation kits, as well as for Agilent,s SureSelect™ ...
Cached Medicine Technology:WaferGen to Present at 13th Annual BIO CEO and Investor Conference 2Caliper Life Sciences Announces Availability of Automated TruSeq™ Next Generation Sequencing Protocols 2
(Date:7/29/2014)... This Latest Guidebook for Conducting Pharma Clinical Trials ... only provided a comprehensive and thorough knowledge of the ... registration but also introduced the practical operation how to ... use the Chinese trial venues to keep drug development ... step. , The audiences of this guidebook are overseas ...
(Date:7/29/2014)... controversy over how best to treat patients after they,ve ... until the cancer comes back or provide men with ... a new study from Thomas Jefferson University ... patients make a more informed decision. , "We are ... author Robert Den, M.D., Assistant Professor of Radiation Oncology ...
(Date:7/29/2014)... principle suitable to find out which preferences patients have ... health economic evaluations, some (primarily methodological) issues still need ... pilot project by the German Institute for Quality and ... Process (AHP), CA is the second method tested by ... outcome-specific results to an overall value , In ...
(Date:7/29/2014)... repeatedly shown that death rates rise in association with ... in the summer of 2003, for example, resulted in ... by Dr. Alex-andra Schneider at the Institute of Epidemiology ... of extreme temperatures on the number of deaths caused ... both high and low temperatures in the study. , ...
(Date:7/29/2014)... stressful situations better than others, and it,s not ... differences in how they respond. , Researchers have ... of genetically identical mice that predicts how well ... , The findings, published July 29 in ... potential consequences of chronic stress -- such as ...
Breaking Medicine News(10 mins):Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:Genomic analysis of prostate cancer indicates best course of action after surgery 2Health News:Determine patient preferences by means of conjoint analysis 2Health News:Determine patient preferences by means of conjoint analysis 3Health News:Determine patient preferences by means of conjoint analysis 4Health News:Mortality rates increase due to extreme heat and cold 2Health News:A new brain-based marker of stress susceptibility 2
... 26 Concentric Medical, Inc., the global leader in ... announced that the company,s Merci Retrieval System(TM) has been ... August 2004. The Merci Retrieval System is a ... remove blood clots from patients suffering an ischemic stroke. ...
... Group at Frost & Sullivan is ... Presentation on the European Orphan Diseases Market to ... 2 p.m. GMT.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )Today,s pharmaceutical companies ... market because of the patent expiry of blockbuster ...
... of advanced health screening solutions in local communities, announces the deployment ... make the investment in the new unit in response to increased ... to increased capacity requirements related to the company,s planned geographical expansion ... ...
... Inc. anticipates growth and expansion of telemedicine services to include ... mental health centers. , ... N. ... continues to advance, regulations pertaining to hospital and physician reimbursement ...
... tumor characteristics that may help indicate which breast cancer patients ... to remove the unaffected breast. Published in the March ... of the American Cancer Society, the study could help patients ... diagnosed with breast cancer are known to be at increased ...
... procedure to remove the unaffected breast in breast cancer patients ... patients who have high-risk features as assessed by examining the ... to researchers at The University of Texas M. D. Anderson ... 1, 2009 issue of Cancer , may help physicians ...
Cached Medicine News:Health News:Concentric Medical Reaches Important Stroke Milestone 2Health News:Concentric Medical Reaches Important Stroke Milestone 3Health News:Frost & Sullivan to Host Analyst Briefing on the European Orphan Diseases Market: Niche-Busters - An Attractive Future? 2Health News:HealthYes! Announces Deployment of a New Mobile Health Screening Unit 2Health News:HealthYes! Announces Deployment of a New Mobile Health Screening Unit 3Health News:A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009 2Health News:Study examines risk factors for cancer in unaffected breast of breast cancer patients 2Health News:Researchers identify risk factors for contralateral breast cancer 2
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... BchiVac V-500 with Vacuum Controller V-800 Efficiently ... turns V-500 on and off as needed to maintain ... Model V-500 is a powerful PTFE membrane vacuum pump ... Ideally suited for use with up to two ...
... V-1000 is a new addition to the powerful ... high performance pump can achieve an ultimate vacuum ... 64 L/min. Applications For use ... Distillation applications from lab size up ...
... is a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with up to ... for instruments including vacuum ovens, concentrators, gel dryers, ... PEEK head resistant to chemicals and heat ...
Medicine Products: